Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma or Multiple Myeloma

Conditions:   Relapse or Refractory Acute Myeloid Leukemia;   Relapse or Refractory Non-Hodgkin Lymphoma;   Relapse or Refractory Multiple Myeloma Intervention:   Drug: S65487 Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials